Marshall Wace, LLP Sanara Med Tech Inc. Transaction History
Marshall Wace, LLP
- $74.4 Billion
- Q1 2025
A detailed history of Marshall Wace, LLP transactions in Sanara Med Tech Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 29,274 shares of SMTI stock, worth $848,946. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,274
Previous 30,285
3.34%
Holding current value
$848,946
Previous $1.01 Million
10.15%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SMTI
# of Institutions
47Shares Held
912KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY197KShares$5.71 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA196KShares$5.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA88.8KShares$2.57 Million0.0% of portfolio
-
State Street Corp Boston, MA63.3KShares$1.84 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL40.8KShares$1.18 Million0.0% of portfolio
About Sanara MedTech Inc.
- Ticker SMTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 8,303,730
- Market Cap $241M
- Description
- Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and...